Allogene Therapeutics, Inc. (ALLO)
NASDAQ·Healthcare·Biotechnology
$1.98
+3.95%
Mkt Cap $463.35M
Analyst Ratings
Buy
6
Hold
1
Sell
0
Price Target (12 analysts)
$6.43
Range $3.85 – $9.00
Implied Upside
+225.6%
Consensus $6.43 vs current $1.98
NASDAQ·Healthcare·Biotechnology
$1.98
+3.95%
Mkt Cap $463.35M
Buy
6
Hold
1
Sell
0
Price Target (12 analysts)
$6.43
Range $3.85 – $9.00
+225.6%
Consensus $6.43 vs current $1.98